Evaluating 111In Panitumumab for Nodal Staging in Head and Neck Cancer
Evaluating 111In Panitumumab for Nodal Staging in Head and Neck Cancer
Recruiting · NCT05901545 · Registry updated 2026-03-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluating 111In Panitumumab for Nodal Staging in Head and Neck Cancer | Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, neoplasm, squamous cell carcinoma | Recruiting | Phase 1 | 2026-03-05 | NCT05901545 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| American Cancer Society, Inc. | 60 |
| Vanderbilt-Ingram Cancer Center | 42 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Vanderbilt University/Ingram Cancer Center | Nashville | United States | 259 |